Table 4. Univariate analysis of disease free survival analysis for NF-pNET patients.
| Patient characteristics | (Number of patient) | Hazard ratio | 95% CI | p-value |
|---|---|---|---|---|
| All patients (20) | ||||
| Gender | Male (8) vs. Female (12) | 3.793 | 0.3071 to 46.83 | 0.256 |
| Age | ≥54 (10) vs. <54 (10) | 9.499 | 0.0104 to 1.060 | 0.056 |
| Grade | G2 (13) vs. G1 (7) | 2.369 | 0.2353 to 23.86 | 0.464 |
| Tumor size | ≥17 mm (10) vs. <17 mm (10) | 10.15 | 0.9559 to 107.9 | 0.054 |
| T | T3,4 (3) vs. T1,2 (17) | 33.98 | 2.7520 to 419.6 | 0.006* |
| N | N1 (7) vs. N0 (13) | 16.48 | 1.5520 to 175.1 | 0.020* |
| M | M1 (2) vs. M0 (18) | 2.969 | 0.1413 to 62.39 | 0.483 |
| Stage | III/IV (7) vs. I/II (13) | 16.48 | 1.5520 to 175.1 | 0.020* |
| anti-EID3 Abs | positive (7) vs. negative (13) | 10.78 | 1.0700 to 108.5 | 0.043* |
NF-pNET: non-functional pancreatic neuroendocrine tumor, CI: confidence interval, Abs: antibodies
*p < 0.05